XML 39 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 5 - Reconciliation of Common Shareholders' Equity, Common Shares and Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2018
Notes Tables  
Schedule of Stockholders Equity [Table Text Block]
(in thousands)
 
Par Value,
Common
Shares
   
Premium
on
Common
Shares
   
Retained
Earnings
   
Accumulated
Other
Comprehensive
Loss
   
Total
Common
Equity
 
Balance, December 31, 2017
  $
197,787
    $
343,450
    $
161,286
    $
(5,631
)   $
696,892
 
Common Stock Issuances, Net of Expenses
   
638
     
(638
)    
 
     
 
     
--
 
Common Stock Retirements
   
(292
)    
(2,117
)    
 
     
 
     
(2,409
)
Net Income
   
 
     
 
     
26,215
     
 
     
26,215
 
Other Comprehensive Loss
   
 
     
 
     
 
     
(502
)    
(502
)
Employee Stock Incentive Plans Expense
   
 
     
1,146
     
 
     
 
     
1,146
 
Common Dividends ($0.335 per share)
   
 
     
 
     
(13,292
)    
 
     
(13,292
)
Balance, March 31, 2018
  $
198,133
    $
341,841
    $
174,209
    $
(6,133
)   $
708,050
 
Schedule of Common Stock Outstanding Roll Forward [Table Text Block]
Common Shares Outstanding, December 31, 2017
   
39,557,491
 
Issuances:
       
Executive Stock Performance Awards (2015 shares earned)
   
114,648
 
Vesting of Restricted Stock Units
   
12,950
 
Retirements:
       
Shares Withheld for Individual Income Tax Requirements
   
(58,495
)
Common Shares Outstanding, March 31, 2018
   
39,626,594
 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
2018
   
2017
 
Weighted Average Common Shares Outstanding – Basic
   
39,550,874
     
39,350,802
 
Plus Outstanding Share Awards net of Share Reductions for Unrecognized Stock-Based Compensation Expense and Excess Tax Benefits:
               
Shares Expected to be Awarded for Stock Performance Awards Granted to Executive Officers based on Measurement Period-to-Date Performance
   
223,162
     
201,639
 
Underlying Shares Related to Nonvested Restricted Stock Units Granted to Employees
   
59,130
     
57,873
 
Nonvested Restricted Shares
   
27,643
     
27,069
 
Shares Expected to be Issued Under the Deferred Compensation Program for Directors
   
2,873
     
3,342
 
Total Dilutive Shares
   
312,808
     
289,923
 
Weighted Average Common Shares Outstanding – Diluted
   
39,863,682
     
39,640,725